Pharmacologic, nonhormonal treatment of impotence. Evaluation of associated factors

M. Savion*, E. Secenreich, E. Kahan, C. Servadio

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


A group of impotent patients previously treated with Strychiomel was evaluated. Strychiomel is a compound of three drugs, yohimbine, thioridazine (Mellaril), and strychnine sulfate, each of which has a specific effect. The results suggest that the compound drug may be beneficial in the majority of patients (66.7%) when impotence occurs without hormonal or severe vascular or psychologic problems. Other factors such as age or presence of other simultaneous diseases do not appear to be significant when treatment with this multiaction drug (Strychiomel) is utilized.

Original languageEnglish
Pages (from-to)510-512
Number of pages3
Issue number5
StatePublished - May 1987
Externally publishedYes


Dive into the research topics of 'Pharmacologic, nonhormonal treatment of impotence. Evaluation of associated factors'. Together they form a unique fingerprint.

Cite this